Q1 2025 Management View CEO Troy Wilson highlighted significant progress in clinical and regulatory milestones, including the submission of a New Drug Application (NDA) for ziftomenib as a monotherapy ...

After Hunter became too weak to walk to classes, she underwent a blood test. When doctors received the results, they urged ...

Princess Margaret Cancer Center at University Health Network-led researchers constructed a detailed single-cell atlas of ...

A highly sensitive bone marrow test could double survival rates for some groups of younger adults with acute myeloid leukemia ...

A phase 1 trial evaluating SENTI-202 demonstrated positive preliminary results in treating relapsed/refractory acute myeloid ...

Scientists have developed a new, ready-made way to fight acute myeloid leukemia and other blood cancers that looks promising.

The Chris Bradley Memorial Blood Drive is going on from 10 a.m. to 6 p.m. at the United Methodist Church on King Avenue.

George Morford has a rare and aggressive form of leukemia, and his life could depend on a stem cell treatment. The challenge ...

A phase 1 trial has initiated and is investigating treatment with ziftomenib plus Gleevec in advanced GIST following ...

Acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML) are the most common pediatric cancers and among the ...

From a meeting that celebrates basic research and being "first," a look at 3 data sets on therapies that would break new ...

TriStar Centennial, through Sarah Cannon Research Institute, will be part of CERo Therapeutics Holdings’s phase 1 clinical ...